Therapeutic Vaccine Market by IndustryARC

Therapeutic Vaccine Market By Materials, By Product, By Preparation Method, By Application and By Geography Analysis - Forecast 2019 - 2024 www.industryarc.com

Therapeutic Vaccine Market 2019-2024

sales@industryarc.com

Industry Market Research for Business Leaders, Strategists, Decision Makers

Press Release

Rising incidences of various chronic illnesses such as cancer, HIV and cardiovascular diseases, innovative and effective vaccines present in the healthcare industry and increasing governmental funding for vaccine development are some of the factors proliferating the demand of therapeutic vaccine, as per the market research report from IndustryARC. The report has assessed the global therapeutic vaccine market valued $19.62 billion in 2018. Furthermore, the market is projected to increase at a CAGR of 36.52% during the forecast period 2019-2025. The report is titled “Therapeutic Vaccine Market: By Vaccine Type (Addiction, Neurological, Infectious, and Autoimmune); By Technology (Autologous, Allogenic) and By Region – Forecast (2019-2025).” It consolidates an in-depth analysis of the imperative aspects of the market including market drivers, market value chain, restraints, growth indicators, market trends, challenges, future outlook, and market insights. Therapeutic Vaccine Market: Leading Segments North America constitute a dominant regional share accounted 46% of global market in 2018. Growing initiatives by healthcare centers, improving recommended immunization, rising adoption of advanced technology in healthcare, improved infrastructure and increasing healthcare expenditure are some important factors that have rendered North America with maximum demand share in the therapeutic vaccine market. Therapeutic vaccine market is segmented on basis of type into addiction vaccines, autoimmune disease vaccines, cancer vaccines, infectious disease vaccines, neurological disease vaccines and Parkinson’s disease vaccines. Among these, autoimmune disease vaccines is found to be the major application segment. As per the recent studies by American Autoimmune Related Diseases Association, autoimmune diseases are affecting nearly 50 million Americans, boosting the usage of autoimmune disease vaccine for treatment.[1] Resultantly, key market players have capitalized on this application segment which is expected to grow with a CAGR of 18% through to 2025.

Therapeutic Vaccine Market Disruptive Trends Certain number of innovative technologies are being developed in accordance with the development of new vaccines. Some of the latest disruptive trends are listed below: ·

Single injection systems with self-locking syringe:

Therapeutic Vaccine Market

It is designed to limit the problem of reutilization of needles. This technology simplifies intradermal injection by using a small needle than a conventional one. Furthermore, patches comprising a set of micro-needles also used for intradermal injection are currently under development. Single injection systems with self-locking syringe technology is dominating the therapeutic vaccine market. Âˇ

Jet Injector:

As per the studies of Clinical, Cosmetic and Investigational Dermatology (CCID), jet injector is gaining momentum in therapeutic vaccine market. All safety concerns associated with needles are eliminated by jet injectors as vaccines are injected using gas or air pressurized systems. Âˇ

Nasal Vaccine:

The therapeutic vaccine market has been disrupted by the development of alternate administration routes namely nasal, intranasal, oral, topical, pulmonary, vaginal, and rectal. The nasal route offers the most promising opportunity for vaccine administration. It amplifies safety, convenience and elicit both local and systemic immune responses, therefore providing protection from pathogens while vaccination. Therapeutic Vaccine Market: Competitive Landscape Major companies currently holding majority or market share in the global therapeutic vaccine market are themare Cytos Biotechnology AG, Agenus, Inc., Pfizer, Merck & Co., Dendreon Corp., GlaxoSmithKline, Biocon, Argos Therapeutic Inc., Novartis AG and Celtic Pharma.

Talk to one of our sales representative about the full report by providing your details in the link below: https://industryarc.com/support.php?id= 16292

Related Reports: A.

DNA Vaccines Market

https://industryarc.com/Report/16032/dna-vaccines-market.html B.

Veterinary Vaccines Market

https://industryarc.com/PressRelease/881/Veterinary-Vaccines-Market-Research.html

What can you expect from the report?

Therapeutic Vaccine Market

The therapeutic vaccine market is prepared with the main agenda to cover the following 20 points: 1. Market Size by Product Categories & Application (Revenue & 2. Market trends & Relevant Market Data

11. Demand Analysis Volume) 12. Country level Analysis

3. Manufacturer Landscape

13. Competitor Analysis

4. Distributor Landscape

14. Market Shares Analysis

5. Pricing Analysis

15. Value Chain Analysis

6. Top 10 End user Analysis

16. Supply Chain Analysis

7. Product Benchmarking

17. Strategic Analysis

8. Product Developments Landscape 9. Mergers & Acquisition Analysis

18. Current & Future Market Analysis 19. Opportunity Analysis

10. Patent Analysis Analysis

20. Revenue and Volume

Q. Does IndustryARC provide customized reports and charge additionally for limited customization? Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization: 1. Increase the level of data in application or end user industry. 2. Increase the number of countries in geography chapter. 3. Find out market shares for other smaller companies or companies which are of interest to you. 4. Company profiles can be requested based on your interest. 5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

To request for a proposal, provide your details in the below link:

Therapeutic Vaccine Market

https://industryarc.com/reports/request-quote?id=16292

Media Contact: Mr. Venkat Reddy Sales Manager Email 1: sales@industryarc.com Or Email 2: venkat@industryarc.com Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare. Reference: [1] https://www.aarda.org

Therapeutic Vaccine Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

Table of Contents 1. Therapeutic Vaccine Market - Overview 1.1. Definitions and Scope 2. Therapeutic Vaccine Market - Executive summary 2.1. Market Revenue, Market Size and Key Trends by Company 2.2. Key Trends by type of Application 2.3. Key Trends segmented by Geography 3. Therapeutic Vaccine Market 3.1. Comparative analysis 3.1.1. Product Benchmarking - Top 10 companies 3.1.2. Top 5 Financials Analysis 3.1.3. Market Value split by Top 10 companies 3.1.4. Patent Analysis - Top 10 companies 3.1.5. Pricing Analysis 4. Therapeutic Vaccine Market – Startup companies Scenario 4.1. Top 10 startup company Analysis by 4.1.1. Investment 4.1.2. Revenue 4.1.3. Market Shares 4.1.4. Market Size and Application Analysis 4.1.5. Venture Capital and Funding Scenario 5. Therapeutic Vaccine Market – Industry Market Entry Scenario 5.1. Regulatory Framework Overview 5.2. New Business and Ease of Doing business index 5.3. Case studies of successful ventures 5.4. Customer Analysis – Top 10 companies 6. Therapeutic Vaccine Market Forces 6.1. Drivers 6.2. Constraints 6.3. Challenges 6.4. Porters five force model 6.4.1. Bargaining power of suppliers 6.4.2. Bargaining powers of customers 6.4.3. Threat of new entrants 6.4.4. Rivalry among existing players 6.4.5. Threat of substitutes 7. Therapeutic Vaccine Market -Strategic analysis 7.1. Value chain analysis 7.2. Opportunities analysis 7.3. Product life cycle 7.4. Suppliers and distributors Market Share 8. Therapeutic Vaccine Market – By Type (Market Size -$Million / $Billion) 8.1. Market Size and Market Share Analysis 8.2. Application Revenue and Trend Research 8.3. Product Segment Analysis 8.3.1. Addiction Vaccines 8.3.1.1. Cocaine Addiction Vaccines 8.3.1.2. Nicotine Addiction Vaccines 8.3.2. Autoimmune Disease Vaccines 8.3.2.1. Diabetes (Type 1)

Therapeutic Vaccine Market

8.3.2.1. Diamyd (RHGAD65) 8.3.2.2. BHT-3021 8.3.2.3. Tovaxin 8.3.2.4. TNFaKinoid 8.3.2.2. Cancer Vaccines 8.3.2.2.1. Cancer vaccines in development 8.3.2.2.2. Cancer vaccines approved for use 8.3.3. Infectious Disease Vaccines 8.3.3.1 HIV/AIDS 8.3.3.2. Other infectious disease vaccines (outside HIV) 8.3.3.3. Hepatitis C 8.3.4. Neurological disease vaccines 8.3.4.1. Parkinsonâ&#x20AC;&#x2122;s disease vaccine 8.3.4.2. Other disease vaccines 9. Therapeutic Vaccine Market â&#x20AC;&#x201C; By Technology (Market Size -$Million / $Billion) 9.1. Autologous Vaccine 9.2. Allogeneic Vaccine 10. Therapeutic Vaccine - By Geography (Market Size -$Million / $Billion) 10.1. Therapeutic Vaccine Market - North America Segment Research 10.2. North America Market Research (Million / $Billion) 10.2.1. Segment type Size and Market Size Analysis 10.2.2. Revenue and Trends 10.2.3. Application Revenue and Trends by type of Application 10.2.4. Company Revenue and Product Analysis 10.2.5. North America Product type and Application Market Size 10.2.5.1. U.S. 10.2.5.2. Canada 10.2.5.3. Mexico 10.2.5.4. Rest of North America 10.3. Therapeutic Vaccine - South America Segment Research 10.4. South America Market Research (Market Size -$Million / $Billion) 10.4.1. Segment type Size and Market Size Analysis 10.4.2. Revenue and Trends 10.4.3. Application Revenue and Trends by type of Application 10.4.4. Company Revenue and Product Analysis 10.4.5. South America Product type and Application Market Size 10.4.5.1. Brazil 10.4.5.2. Venezuela 10.4.5.3. Argentina 10.4.5.4. Ecuador 10.4.5.5. Peru 10.4.5.6. Colombia 10.4.5.7. Costa Rica 10.4.5.8. Rest of South America 10.5. Therapeutic Vaccine - Europe Segment Research 10.6. Europe Market Research (Market Size -$Million / $Billion) 10.6.1. Segment type Size and Market Size Analysis 10.6.2. Revenue and Trends 10.6.3. Application Revenue and Trends by type of Application 10.6.4. Company Revenue and Product Analysis 10.6.5. Europe Segment Product type and Application Market Size 10.6.5.1. U.K 10.6.5.2. Germany 10.6.5.3. Italy 10.6.5.4. France 10.6.5.5. Netherlands 10.6.5.6. Belgium 10.6.5.7. Spain

Therapeutic Vaccine Market

10.6.5.8. Denmark 10.6.5.9. Rest of Europe 10.7. Therapeutic Vaccine – APAC Segment Research 10.8. APAC Market Research (Market Size -$Million / $Billion) 10.8.1. Segment type Size and Market Size Analysis 10.8.2. Revenue and Trends 10.8.3. Application Revenue and Trends by type of Application 10.8.4. Company Revenue and Product Analysis 10.8.5. APAC Segment – Product type and Application Market Size 10.8.5.1. China 10.8.5.2. Australia 10.8.5.3. Japan 10.8.5.4. South Korea 10.8.5.5. India 10.8.5.6. Taiwan 10.8.5.7. Malaysia 11. Therapeutic Vaccine Market - Entropy 11.1. New product launches 11.2. M&A's, collaborations, JVs and partnerships 12. Therapeutic Vaccine Market – Industry / Segment Competition landscape 12.1. Market Share Analysis 12.1.1. Market Share by Country- Top companies 12.1.2. Market Share by Region- Top 10 companies 12.1.3. Market Share by type of Application – Top 10 companies 12.1.4. Market Share by type of Product / Product category- Top 10 companies 12.1.5. Market Share at global level- Top 10 companies 12.1.6. Best Practises for companies 13. Therapeutic Vaccine Market – Key Company List by Country 14. Therapeutic Vaccine Market Company Analysis 14.1. Market Share, Company Revenue, Products, M&A, Developments 14.2. Agenus, Inc. 14.3. GlaxoSmithKline 14.4. Novartis AG 14.5. Pfizer 14.6. Argos Therapeutic Inc. 14.7. Merck & Co. 14.8. Celldex Therapeutic Inc. 14.9. Cytos Biotechnology AG 14.10. Dendreon Corp 14.11. Vaccinogen, Inc. 14.12. Company 12 14.13. Company 13 14.14. Company 14 and more "*Financials would be provided on a best efforts basis for private companies" 15. Therapeutic Vaccine Market -Appendix 15.1. Abbreviations 15.2. Sources 16. Therapeutic Vaccine Market -Methodology 16.1. Research Methodology 16.1.1. Company Expert Interviews 16.1.2. Industry Databases 16.1.3. Associations 16.1.4. Company News 16.1.5. Company Annual Reports 16.1.6. Application Trends 16.1.7. New Products and Product database 16.1.8. Company Transcripts 16.1.9. R&D Trends

Therapeutic Vaccine Market

16.1.10. Key Opinion Leaders Interviews 16.1.11. Supply and Demand Trends

Therapeutic Vaccine Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

IndustryARC Solutions We cater to the pain points of our clients by providing the following solutions, which are targeted and address key issues specifically. Each of the business verticals is helpful to a client at various stages of their operational, managerial and strategic level plans. Syndicate Reports and Consulting (SRC) 1. Provide high quality analytical syndicated reports with key market insights, strategies and market forecasts for a specific industry or vertical of the clients. Constant tracking of industries and relations with experts helps us to predict and publish reports before our competitors as well as meet client needs proactively. Market Research and Data Analytics (MRDA) 2. Provide pure play data analytics services for ad-hoc and long-term engagement projects of clients with market research layered into the analysis. We are the only global company to offer this combination one-stop service to clients. Redundancies generally seen by procuring data, analytics services from multiple vendors is overcome by our solution. Competitive Landscape Analysis (CLA) 3. Provide company financial analysis, market share analysis, competitive landscape insights and market movements to clients. This is one of the most important pain point and key request from majority of our clients, for which we use our proprietary methodologies to provide accurate CLA data. Accelerated Business Development (ABD) 4. Connect clients with their customers on a global scale by acting as an outsourced sales team on behalf of the client. This is a unique tri-party engagement model to benefit the client and their customer, and acts as a business development scale up at an international level. Market Intel Reports (MIR) 5. Provide one-stop venue with a searchable syndicate reports database from global companies available to clients. This augments our offerings exponentially and also assists in studying global client needs at an in-depth level.

Therapeutic Vaccine Market

010

Industry Market Research for Business Leaders, Strategists, Decision Makers

About IndustryARC IndustryARC strategy studies primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals.

We Work for You For IndustryARC, we value every customer equally. We only stay ready to help each client in the best way possible with a unique 24x365 support plan. We suggest looking at the following benefits of relying on Professional Business Consulting and Custom Market Research Services to realize the unique strategic gains on offer: 1. 2. 3. 4. 5. 6. 7.

Strengthen and improve organizational performance Strategic planning and analysing Adoption of newer and cost-effective technologies Become environmentally sustainable and profitable Improve their training and certification procedures. Planning for business automation. Project facilitation and management.

Therapeutic Vaccine Market

011

Therapeutic Vaccine Market

012